Mazetol 200 Tablet contains Carbamazepine 200 mg, an anticonvulsant and mood-stabilizing agent primarily indicated for the treatment of epilepsy, trigeminal neuralgia, and bipolar disorder. Carbamazepine acts by inhibiting voltage-gated sodium channels, stabilizing hyperexcited nerve membranes, and reducing synaptic transmission, thereby preventing the propagation of abnormal electrical discharges in the brain. Mazetol 200 is effective in controlling partial seizures with complex symptomatology, generalized tonic-clonic seizures, and mixed seizure types. Additionally, it is utilized to alleviate neuropathic pain associated with trigeminal neuralgia and to manage acute manic and mixed episodes in bipolar disorder. The medication is administered orally, with dosage individualized based on clinical response and patient tolerance. Common adverse effects include dizziness, drowsiness, nausea, and ataxia, while serious but rare reactions may involve agranulocytosis, aplastic anemia, and Stevens-Johnson syndrome, necessitating regular hematological monitoring during therapy. Caution is advised in patients with hepatic or renal impairment, and potential drug interactions should be assessed due to Carbamazepine’s enzyme-inducing properties. Mazetol 200 should be used under strict medical supervision to optimize therapeutic outcomes and minimize risks.